We estimate the company to post Revenue/EBITDA/PAT growth of 10%/12%/12% CAGR over FY23-26E and maintain a BUY rating on the stock with an unchanged TP of Rs 540/share. We value the company at 27x June-25 EPS. The TP implies an upside of 20% from the CMP.